Obizur® (antihemophilic factor (recombinant), porcine sequence)
for Hemophilia

Obizur is a recombinant porcine sequence factor VIII therapy used to control and prevent bleeding episodes in people with hemophilia A. It is also administered before surgery to reduce bleeding risk. Obizur temporarily replaces missing factor VIII, supporting blood clotting and helping prevent prolonged or spontaneous bleeding, particularly in joints and muscles.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hemophilia